All terms in NCIT
| Label | Id | Description |
|---|---|---|
| WHODAS 2.0 12-item Version Self-administered - Dealing With People You Do Not Know | NCIT_C130944 | [World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered (WHODAS 2.0 12-item Version Self-administered) In the past 30 days, how much difficulty did you have in: Dealing with people you do not know?] |
| pT2c Stage Finding | NCIT_C48767 | [A pathologic primary tumor TNM stage finding. The definition of pT2c stage finding depends on the particular type of cancer that it refers to; for example, for prostate cancer, pT2c stage finding is defined as follows: cancer involving both lobes of the prostate gland; for fallopian tube cancer, pT2c stage finding is defined as follows: cancer with pelvic extension and malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)] |
| pT3 Stage Finding | NCIT_C48768 | [A pathologic primary tumor TNM stage finding. The definition of pT3 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 stage finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 stage finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.)] |
| pT3a Stage Finding | NCIT_C48769 | [A pathologic primary tumor TNM stage finding. The definition of pT3a stage finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3a stage finding is defined as follows: cancer involves lower third of vagina, without extension to pelvic wall; for kidney cancer, pT3a stage finding is defined as follows: cancer with tumor grossly extending into the renal vein or its segmental (muscle containing) branches or tumor invading perirenal and/or renal sinus fat but not beyond Gerota's fascia. (from AJCC 7th Ed.)] |
| pT4b Stage Finding | NCIT_C48774 | [A pathologic primary tumor TNM stage finding. The definition of pT4b stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4b stage finding is defined as follows: cancer with ulceration and/or ipsilateral satellite nodules and/or edema (including peau d'orange) of the skin, which do not meet the criteria for inflammatory carcinoma; for gastric cancer, pT4b stage finding is defined as follows: cancer with tumor invading adjacent structures. (from AJCC 7th Ed.)] |
| pT4 Stage Finding | NCIT_C48772 | [A pathologic primary tumor TNM stage finding. The definition of pT4 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 stage finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 stage finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.)] |
| pT4c Stage Finding | NCIT_C48775 | |
| pT4d Stage Finding | NCIT_C48776 | |
| Histone-Lysine N-Methyltransferase KMT5C | NCIT_C73700 | [Histone-lysine N-methyltransferase SUV420H2 (462 aa, ~52 kDa) is encoded by the human SUV420H2 gene. This soluble, nuclear protein may play a role in repression of transcription by RNA polymerase II, and in establishment of pericentric heterochromatin domains.] |
| Cancer TNM Vessel Invasion Finding Category | NCIT_C48777 | |
| Generic TNM Finding | NCIT_C48879 | [A cancer finding in the TNM system that is not specifically identified as a clinical, pathologic, recurrent (retreatment), or autopsy classification using an accepted prefix in accordance with TNM classification guidelines. Though the 6th Edition of the AJCC Cancer Staging Manual indicates that unspecified TNM staging descriptors may be considered synonymous with the corresponding fully specified clinical category, such omission may lead to ambiguity in meaning, and in practice unqualified descriptors are frequently used with other intended meanings. The generic TNM concepts in the NCI Thesaurus are intended to explicitly reflect this lack of specification.] |
| pT3b Stage Finding | NCIT_C48770 | [A pathologic primary tumor TNM stage finding. The definition of pT3b stage finding depends on the particular type of cancer that it refers to; for example, for cervical cancer, pT3b stage finding is defined as follows:cancer extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney; for kidney cancer, pT3b stage finding is defined as follows: cancer with tumor grossly extending into the vena cava below the diaphragm. (from AJCC 7th Ed.)] |
| pT3c Stage Finding | NCIT_C48771 | [A pathologic primary tumor TNM stage finding. The definition of pT3c stage finding depends on the particular type of cancer that it refers to; for example, for kidney cancer, pT3c stage finding is defined as follows: cancer with tumor grossly extending into the vena cava above the diaphragm, or invading the wall of the vena cava; for fallopian tube cancer, pT3c stage finding is defined as follows: cancer with peritoneal metastasis outside the pelvis and more than 2 cm in diameter. (from AJCC 7th Ed.)] |
| pT4a Stage Finding | NCIT_C48773 | [A pathologic primary tumor TNM stage finding. The definition of pT4a stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4a stage finding is defined as follows: cancer with extension to the chest wall, not including the pectoralis muscle; for thyroid cancer, pT4a stage finding is defined as follows: cancer with moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. (from AJCC 7th Ed.)] |
| Intermediate | NCIT_C73705 | [Lying between two extremes in time or space or degree.] |
| WHODAS 2.0 12-item Version Proxy-administered - How Many Days Reduce Activities | NCIT_C130934 | [World Health Organization Disability Assessment Schedule 2.0 12-item Version Proxy-administered (WHODAS 2.0 12-item Version Proxy-administered) In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition?] |
| WHODAS 2.0 12-item Version Self-administered - Standing for Long Periods | NCIT_C130935 | [World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered (WHODAS 2.0 12-item Version Self-administered) In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes?] |
| Oblique | NCIT_C73707 | [Slanting or inclined in direction or course or position; neither parallel nor perpendicular nor right-angular.] |
| WHODAS 2.0 12-item Version Self-administered - Care of Household Responsibilities | NCIT_C130936 | [World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered (WHODAS 2.0 12-item Version Self-administered) In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities?] |
| Animal Dosing Unit | NCIT_C73708 |